Neuropathy Pain Treatment Market Research Report by Pain Type, Indication, Treatment, Distribution Channel, End-User, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030- Product Image

Sale

Neuropathy Pain Treatment Market Research Report by Pain Type, Indication, Treatment, Distribution Channel, End-User, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

Report
257 Pages
January 2023
Region: Global
360iResearch™
ID: 5666258

UP TO €852EUR$895USD£747GBP OFF until Mar 31^st 2023

The Global Neuropathy Pain Treatment Market size was estimated at USD 6,974.20 million in 2022, USD 7,740.31 million in 2023, and is projected to grow at a CAGR of 11.46% to reach USD 16,618.49 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Neuropathy Pain Treatment Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Neuropathy Pain Treatment Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Neuropathy Pain Treatment Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Neuropathy Pain Treatment Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Neuropathy Pain Treatment Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Pain Type, the market is studied across Coccydynia, Entrapment Neuropathy, Foot Pain, Peripheral Neuropathy, Phantom Limb Neuropathy, Post Herpetic Neuralgia (PHN), Post Traumatic Neuropathy, and Trigeminal Neuralgia.
Based on Indication, the market is studied across Chemotherapy-Induced Peripheral Neuropathy, Diabetic Neuropathy, and Spinal Stenosis.
Based on Treatment, the market is studied across Drugs and Therapy. The Drugs is is further studied across Antidepressant Drugs Type, Medication Type, Multimodal Therapy, and NSAIDs Type. The Antidepressant Drugs Type is is further studied across Serotonin Noradrenaline and Tricyclic Antidepressants. The NSAIDs Type is is further studied across Ibuprofen and Naproxen.
Based on Distribution Channel, the market is studied across Online Pharmacies and Retail Pharmacies & Drug Stores.
Based on End-User, the market is studied across Clinics and Hospitals.
Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Neuropathy Pain Treatment Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Neuropathy Pain Treatment Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Neuropathy Pain Treatment Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Neuropathy Pain Treatment Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Neuropathy Pain Treatment Market, including Abbott Laboratories, Assertio Holdings, Inc., Astellas Pharma Inc., AstraZeneca PLC, Aurobindo Pharma Limited, Baxter International Inc., Biogen Inc., Bristol Myers Squibb Company, Dr. Reddy’s Laboratories Ltd., Eli Lilly and Company, GlaxoSmithKline PLC, Johnson and Johnson Services, Inc., Novartis AG, Pfizer Inc., and Sun Pharmaceutical Industries Limited.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Neuropathy Pain Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neuropathy Pain Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neuropathy Pain Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Neuropathy Pain Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Neuropathy Pain Treatment Market?
6. What is the market share of the leading vendors in the Global Neuropathy Pain Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Neuropathy Pain Treatment Market?

Frequently Asked Questions about the Global Neuropathy Pain Treatment Market

What is the estimated value of the Global Neuropathy Pain Treatment Market?

The Global Neuropathy Pain Treatment Market was estimated to be valued at $6974.2 Million in 2022.

What is the growth rate of the Global Neuropathy Pain Treatment Market?

The growth rate of the Global Neuropathy Pain Treatment Market is 11.4%, with an estimated value of $16618.49 Million by 2030.

What is the forecasted size of the Global Neuropathy Pain Treatment Market?

The Global Neuropathy Pain Treatment Market is estimated to be worth $16618.49 Million by 2030.

Who are the key companies in the Global Neuropathy Pain Treatment Market?

Key companies in the Global Neuropathy Pain Treatment Market include Abbott Laboratories, Assertio Holdings, Inc., Astellas Pharma Inc., AstraZeneca PLC, Aurobindo Pharma Limited, Baxter International Inc., Biogen Inc., Bristol Myers Squibb Company and Eli Lilly and Company.

Report Attribute	Details
No. of Pages	257
Published	January 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	USD 6974.2 Million
Forecasted Market Value ( USD ) by 2030	USD 16618.49 Million
Compound Annual Growth Rate	11.4%
Regions Covered	Global
No. of Companies Mentioned	15

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in neuropathic pain among population
5.1.1.2. Increasing global healthcare expenditure
5.1.1.3. Growing number of neuropathic pain relievers and over-the-counter products
5.1.2. Restraints
5.1.2.1. Limited awareness of available treatment options
5.1.3. Opportunities
5.1.3.1. Introduction of novel pain treatment alternatives
5.1.3.2. Programs and initiatives focusing on palliative care
5.1.4. Challenges
5.1.4.1. Complexity in identifying the treatment suitable for neuropathic pains in a patient
5.2. Cumulative Impact of COVID-19

6. Neuropathy Pain Treatment Market, by Pain Type

6.1. Introduction
6.2. Coccydynia
6.3. Entrapment Neuropathy
6.4. Foot Pain
6.5. Peripheral Neuropathy
6.6. Phantom Limb Neuropathy
6.7. Post Herpetic Neuralgia (PHN)
6.8. Post Traumatic Neuropathy
6.9. Trigeminal Neuralgia

7. Neuropathy Pain Treatment Market, by Indication

7.1. Introduction
7.2. Chemotherapy-Induced Peripheral Neuropathy
7.3. Diabetic Neuropathy
7.4. Spinal Stenosis

8. Neuropathy Pain Treatment Market, by Treatment

8.1. Introduction
8.2. Drugs
8.3.1. Antidepressant Drugs Type
8.3.2.1. Serotonin Noradrenaline
8.3.2.2. Tricyclic Antidepressants
8.3.2. Medication Type
8.3.3. Multimodal Therapy
8.3.4. NSAIDs Type
8.3.5.1. Ibuprofen
8.3.5.2. Naproxen
8.3. Therapy

9. Neuropathy Pain Treatment Market, by Distribution Channel

9.1. Introduction
9.2. Online Pharmacies
9.3. Retail Pharmacies & Drug Stores

10. Neuropathy Pain Treatment Market, by End-User

10.1. Introduction
10.2. Clinics
10.3. Hospitals

11. Americas Neuropathy Pain Treatment Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Neuropathy Pain Treatment Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Neuropathy Pain Treatment Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion

15. Company Usability Profiles

15.1. Abbott Laboratories
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Assertio Therapeutics Inc.
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Astellas Pharma Inc.
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. AstraZeneca Plc
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Aurobindo Pharma Ltd.
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Baxter International Inc.
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Biogen Inc.
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Bristol Myers Squibb Company
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Depomed, Inc.
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Dr. Reddy’s Laboratories Ltd.
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. Eli Lilly and Company
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Endo International Plc
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. GlaxoSmithKline Plc
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Johnson and Johnson Services, Inc.
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Mallinckrodt Pharmaceuticals
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Novartis AG
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Pfizer Inc.
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. Sanofi
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. Sun Pharmaceutical Industries Ltd
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. Teva Pharmaceutical Industries Ltd.
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services
15.21. VistaGen Therapeutics Inc.
15.21.1. Business Overview
15.21.2. Key Executives
15.21.3. Product & Services

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing

List of Figures

FIGURE 1. GLOBAL NEUROPATHY PAIN TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. GLOBAL NEUROPATHY PAIN TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL NEUROPATHY PAIN TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL NEUROPATHY PAIN TREATMENT MARKET DYNAMICS
FIGURE 11. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2021 VS 2027 (%)
FIGURE 12. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL NEUROPATHY PAIN TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY PAIN TYPE, 2027
FIGURE 14. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COCCYDYNIA, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ENTRAPMENT NEUROPATHY, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY FOOT PAIN, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PERIPHERAL NEUROPATHY, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PHANTOM LIMB NEUROPATHY, 2018-2027 (USD MILLION)
FIGURE 19. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY POST HERPETIC NEURALGIA (PHN), 2018-2027 (USD MILLION)
FIGURE 20. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY POST TRAUMATIC NEUROPATHY, 2018-2027 (USD MILLION)
FIGURE 21. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRIGEMINAL NEURALGIA, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2021 VS 2027 (%)
FIGURE 23. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL NEUROPATHY PAIN TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY INDICATION, 2027
FIGURE 25. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY, 2018-2027 (USD MILLION)
FIGURE 26. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DIABETIC NEUROPATHY, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SPINAL STENOSIS, 2018-2027 (USD MILLION)
FIGURE 28. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2021 VS 2027 (%)
FIGURE 29. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2021 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL NEUROPATHY PAIN TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY TREATMENT, 2027
FIGURE 31. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
FIGURE 32. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2027 (USD MILLION)
FIGURE 33. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SEROTONIN NORADRENALINE, 2018-2027 (USD MILLION)
FIGURE 34. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, 2018-2027 (USD MILLION)
FIGURE 35. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY MEDICATION TYPE, 2018-2027 (USD MILLION)
FIGURE 36. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY MULTIMODAL THERAPY, 2018-2027 (USD MILLION)
FIGURE 37. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2027 (USD MILLION)
FIGURE 38. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY IBUPROFEN, 2018-2027 (USD MILLION)
FIGURE 39. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NAPROXEN, 2018-2027 (USD MILLION)
FIGURE 40. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2018-2027 (USD MILLION)
FIGURE 41. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 42. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD MILLION)
FIGURE 43. GLOBAL NEUROPATHY PAIN TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY DISTRIBUTION CHANNEL, 2027
FIGURE 44. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2027 (USD MILLION)
FIGURE 45. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, 2018-2027 (USD MILLION)
FIGURE 46. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 47. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 48. GLOBAL NEUROPATHY PAIN TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2027
FIGURE 49. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CLINICS, 2018-2027 (USD MILLION)
FIGURE 50. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
FIGURE 51. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 53. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 54. AMERICAS NEUROPATHY PAIN TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 55. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 61. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 62. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 63. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 65. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 66. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 67. AUSTRALIA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. CHINA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. INDIA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. INDONESIA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. JAPAN NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. MALAYSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. PHILIPPINES NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. SINGAPORE NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. SOUTH KOREA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. TAIWAN NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. THAILAND NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. VIETNAM NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 80. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 81. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 82. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 83. DENMARK NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 84. EGYPT NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 85. FINLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 86. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 87. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 88. ISRAEL NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 89. ITALY NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 90. NETHERLANDS NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 91. NIGERIA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 92. NORWAY NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 93. POLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 94. QATAR NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 95. RUSSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 96. SAUDI ARABIA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 97. SOUTH AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 98. SPAIN NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 99. SWEDEN NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 100. SWITZERLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 101. TURKEY NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 102. UNITED ARAB EMIRATES NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 103. UNITED KINGDOM NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 104. GLOBAL NEUROPATHY PAIN TREATMENT MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 105. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 106. GLOBAL NEUROPATHY PAIN TREATMENT MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021

List of Tables

TABLE 1. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COCCYDYNIA, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COCCYDYNIA, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COCCYDYNIA, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ENTRAPMENT NEUROPATHY, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ENTRAPMENT NEUROPATHY, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ENTRAPMENT NEUROPATHY, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY FOOT PAIN, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY FOOT PAIN, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY FOOT PAIN, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PERIPHERAL NEUROPATHY, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PERIPHERAL NEUROPATHY, BY REGION, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PERIPHERAL NEUROPATHY, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PHANTOM LIMB NEUROPATHY, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PHANTOM LIMB NEUROPATHY, BY REGION, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PHANTOM LIMB NEUROPATHY, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY POST HERPETIC NEURALGIA (PHN), 2018-2027 (USD MILLION)
TABLE 23. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY POST HERPETIC NEURALGIA (PHN), BY REGION, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY POST HERPETIC NEURALGIA (PHN), BY REGION, 2018-2027 (USD MILLION)
TABLE 25. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY POST TRAUMATIC NEUROPATHY, 2018-2027 (USD MILLION)
TABLE 26. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY POST TRAUMATIC NEUROPATHY, BY REGION, 2018-2027 (USD MILLION)
TABLE 27. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY POST TRAUMATIC NEUROPATHY, BY REGION, 2018-2027 (USD MILLION)
TABLE 28. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRIGEMINAL NEURALGIA, 2018-2027 (USD MILLION)
TABLE 29. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY REGION, 2018-2027 (USD MILLION)
TABLE 30. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY REGION, 2018-2027 (USD MILLION)
TABLE 31. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 32. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY, 2018-2027 (USD MILLION)
TABLE 33. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY, BY REGION, 2018-2027 (USD MILLION)
TABLE 34. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY, BY REGION, 2018-2027 (USD MILLION)
TABLE 35. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DIABETIC NEUROPATHY, 2018-2027 (USD MILLION)
TABLE 36. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DIABETIC NEUROPATHY, BY REGION, 2018-2027 (USD MILLION)
TABLE 37. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DIABETIC NEUROPATHY, BY REGION, 2018-2027 (USD MILLION)
TABLE 38. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SPINAL STENOSIS, 2018-2027 (USD MILLION)
TABLE 39. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SPINAL STENOSIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 40. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SPINAL STENOSIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 41. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 42. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
TABLE 43. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2027 (USD MILLION)
TABLE 44. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2027 (USD MILLION)
TABLE 45. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2027 (USD MILLION)
TABLE 46. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, BY REGION, 2018-2027 (USD MILLION)
TABLE 47. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, BY REGION, 2018-2027 (USD MILLION)
TABLE 48. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SEROTONIN NORADRENALINE, 2018-2027 (USD MILLION)
TABLE 49. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SEROTONIN NORADRENALINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 50. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SEROTONIN NORADRENALINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 51. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, 2018-2027 (USD MILLION)
TABLE 52. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 53. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 54. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY MEDICATION TYPE, 2018-2027 (USD MILLION)
TABLE 55. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY MEDICATION TYPE, BY REGION, 2018-2027 (USD MILLION)
TABLE 56. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY MEDICATION TYPE, BY REGION, 2018-2027 (USD MILLION)
TABLE 57. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY MULTIMODAL THERAPY, 2018-2027 (USD MILLION)
TABLE 58. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY MULTIMODAL THERAPY, BY REGION, 2018-2027 (USD MILLION)
TABLE 59. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY MULTIMODAL THERAPY, BY REGION, 2018-2027 (USD MILLION)
TABLE 60. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2027 (USD MILLION)
TABLE 61. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, BY REGION, 2018-2027 (USD MILLION)
TABLE 62. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, BY REGION, 2018-2027 (USD MILLION)
TABLE 63. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY IBUPROFEN, 2018-2027 (USD MILLION)
TABLE 64. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY IBUPROFEN, BY REGION, 2018-2027 (USD MILLION)
TABLE 65. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY IBUPROFEN, BY REGION, 2018-2027 (USD MILLION)
TABLE 66. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NAPROXEN, 2018-2027 (USD MILLION)
TABLE 67. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NAPROXEN, BY REGION, 2018-2027 (USD MILLION)
TABLE 68. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NAPROXEN, BY REGION, 2018-2027 (USD MILLION)
TABLE 69. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, 2018-2027 (USD MILLION)
TABLE 70. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, BY REGION, 2018-2027 (USD MILLION)
TABLE 71. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, BY REGION, 2018-2027 (USD MILLION)
TABLE 72. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 73. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2027 (USD MILLION)
TABLE 74. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 75. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 76. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, 2018-2027 (USD MILLION)
TABLE 77. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY REGION, 2018-2027 (USD MILLION)
TABLE 78. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY REGION, 2018-2027 (USD MILLION)
TABLE 79. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 80. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CLINICS, 2018-2027 (USD MILLION)
TABLE 81. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 82. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 83. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
TABLE 84. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
TABLE 85. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
TABLE 86. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 87. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 88. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 89. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 90. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 91. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 92. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 93. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 94. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 95. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 96. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 97. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 98. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 99. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 100. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 101. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 102. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 103. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 104. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 105. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 106. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 107. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 108. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 109. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 110. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 111. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 112. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 113. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 114. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 115. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 116. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 117. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 118. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 119. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 120. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 121. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 122. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 123. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 124. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 125. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 126. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 127. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 128. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 129. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 130. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 131. AUSTRALIA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 132. AUSTRALIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 133. AUSTRALIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 134. AUSTRALIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 135. AUSTRALIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 136. AUSTRALIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 137. CHINA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 138. CHINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 139. CHINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 140. CHINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 141. CHINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 142. CHINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 143. INDIA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 144. INDIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 145. INDIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 146. INDIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 147. INDIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 148. INDIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 149. INDONESIA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 150. INDONESIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 151. INDONESIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 152. INDONESIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 153. INDONESIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 154. INDONESIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 155. JAPAN NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 156. JAPAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 157. JAPAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 158. JAPAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 159. JAPAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 160. JAPAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 161. MALAYSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 162. MALAYSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 163. MALAYSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 164. MALAYSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 165. MALAYSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 166. MALAYSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 167. PHILIPPINES NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 168. PHILIPPINES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 169. PHILIPPINES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 170. PHILIPPINES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 171. PHILIPPINES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 172. PHILIPPINES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 173. SINGAPORE NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 174. SINGAPORE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 175. SINGAPORE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 176. SINGAPORE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 177. SINGAPORE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 178. SINGAPORE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 179. SOUTH KOREA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 180. SOUTH KOREA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 181. SOUTH KOREA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 182. SOUTH KOREA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 183. SOUTH KOREA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 184. SOUTH KOREA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 185. TAIWAN NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 186. TAIWAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 187. TAIWAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 188. TAIWAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 189. TAIWAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 190. TAIWAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 191. THAILAND NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 192. THAILAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 193. THAILAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 194. THAILAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 195. THAILAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 196. THAILAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 197. VIETNAM NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 198. VIETNAM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 199. VIETNAM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 200. VIETNAM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 201. VIETNAM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 202. VIETNAM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 210. DENMARK NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 211. DENMARK NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 212. DENMARK NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 213. DENMARK NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 214. DENMARK NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 215. DENMARK NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 216. EGYPT NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 217. EGYPT NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 218. EGYPT NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 219. EGYPT NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 220. EGYPT NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 221. EGYPT NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 222. FINLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 223. FINLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 224. FINLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 225. FINLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 226. FINLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 227. FINLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 228. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 229. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 230. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 231. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 232. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 233. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 234. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 235. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 236. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 237. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 238. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 239. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 240. ISRAEL NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 241. ISRAEL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 242. ISRAEL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 243. ISRAEL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 244. ISRAEL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 245. ISRAEL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 246. ITALY NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 247. ITALY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 248. ITALY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 249. ITALY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 250. ITALY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 251. ITALY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 252. NETHERLANDS NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 253. NETHERLANDS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 254. NETHERLANDS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 255. NETHERLANDS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 256. NETHERLANDS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 257. NETHERLANDS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 258. NIGERIA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 259. NIGERIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 260. NIGERIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 261. NIGERIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 262. NIGERIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 263. NIGERIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 264. NORWAY NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 265. NORWAY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 266. NORWAY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 267. NORWAY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 268. NORWAY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 269. NORWAY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 270. POLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 271. POLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 272. POLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 273. POLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 274. POLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 275. POLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 276. QATAR NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 277. QATAR NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 278. QATAR NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 279. QATAR NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 280. QATAR NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 281. QATAR NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 282. RUSSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 283. RUSSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 284. RUSSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 285. RUSSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 286. RUSSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 287. RUSSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 288. SAUDI ARABIA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 289. SAUDI ARABIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 290. SAUDI ARABIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 291. SAUDI ARABIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 292. SAUDI ARABIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 293. SAUDI ARABIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 294. SOUTH AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 295. SOUTH AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 296. SOUTH AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 297. SOUTH AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 298. SOUTH AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 299. SOUTH AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 300. SPAIN NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 301. SPAIN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 302. SPAIN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 303. SPAIN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 304. SPAIN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 305. SPAIN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 306. SWEDEN NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 307. SWEDEN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 308. SWEDEN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 309. SWEDEN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 310. SWEDEN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 311. SWEDEN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 312. SWITZERLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 313. SWITZERLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 314. SWITZERLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 315. SWITZERLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 316. SWITZERLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 317. SWITZERLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 318. TURKEY NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 319. TURKEY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 320. TURKEY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 321. TURKEY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 322. TURKEY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 323. TURKEY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2027 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2027 (U